ft.com The coronavirus disease (COVID-19) vaccine made by Pfizer-BioNTech has 91 percent efficacy in children aged five to 11 years old, a member of the National Immunization Technical Advisory Group (NITAG) said on Wednesday, Jan. 26. “The vaccine efficacy for the adolescents age group (12 to...